Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

991 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Evaluation of Renal Impairment in Patients with Diabetic Kidney Disease by Integrated Chinese and Western Medicine.
Qu YL, Dong ZY, Cheng HM, Liu Q, Wang Q, Yang HT, Mao YH, Li JJ, Liu HF, Geng YQ, Huang W, Liu WH, Xie HD, Peng F, Li S, Jiang SS, Li WZ, Duan SW, Feng Z, Zhang WG, Liu YN, Tian JZ, Chen XM. Qu YL, et al. Among authors: liu wh, liu yn, liu q, liu hf. Chin J Integr Med. 2023 Apr;29(4):308-315. doi: 10.1007/s11655-022-3520-0. Epub 2022 Jun 9. Chin J Integr Med. 2023. PMID: 35679002 Clinical Trial.
Efficacy and Safety of Niaoduqing Particles for Delaying Moderate-to-severe Renal Dysfunction: A Randomized, Double-blind, Placebo-controlled, Multicenter Clinical Study.
Zheng Y, Cai GY, He LQ, Lin HL, Cheng XH, Wang NS, Jian GH, Liu XS, Liu YN, Ni ZH, Fang JA, Ding HL, Guo W, He YN, Wang LH, Wang YP, Yang HT, Ye ZM, Yu RH, Zhao LJ, Zhou WH, Li WG, Mao HJ, Zhan YL, Hu Z, Yao C, Wei RB, Chen XM. Zheng Y, et al. Among authors: liu yn, liu xs. Chin Med J (Engl). 2017 Oct 20;130(20):2402-2409. doi: 10.4103/0366-6999.216407. Chin Med J (Engl). 2017. PMID: 29052559 Free PMC article. Clinical Trial.
Effects of Niaoduqing Particles () on Delaying Progression of Renal Dysfunction: A Post-trial, Open-Label, Follow-up Study.
Zheng Y, Wang NS, Liu YN, He LQ, Jian GH, Liu XS, Ni ZH, Cheng XH, Lin HL, Zhou WH, Wang YP, Fang JA, He YN, Yang HT, Zhao LJ, Ding HL, Wang LH, Yu RH, Li WG, Ye ZM, Guo W, Zhan YL, Mao HJ, Hu Z, Yao C, Cai GY, Chen XM. Zheng Y, et al. Among authors: liu yn, liu xs. Chin J Integr Med. 2019 Mar;25(3):168-174. doi: 10.1007/s11655-018-2998-y. Epub 2018 Nov 22. Chin J Integr Med. 2019. PMID: 30467695 Clinical Trial.
Bupi Yishen Formula Versus Losartan for Non-Diabetic Stage 4 Chronic Kidney Disease: A Randomized Controlled Trial.
Mao W, Yang N, Zhang L, Li C, Wu Y, Ouyang W, Xu P, Zou C, Pei C, Shi W, Zhan J, Yang H, Chen H, Wang X, Tian Y, Yuan F, Sun W, Xiong G, Chen M, Guan J, Tang S, Zhang C, Liu Y, Deng Y, Lin Q, Lu F, Hong W, Yang A, Fang J, Rao J, Wang L, Bao K, Lin F, Xu Y, Lu Z, Su G, Zhang L, Johnson DW, Zhao D, Hou H, Fu L, Guo X, Yang L, Qin X, Wen Z, Liu X. Mao W, et al. Front Pharmacol. 2021 Jan 29;11:627185. doi: 10.3389/fphar.2020.627185. eCollection 2020. Front Pharmacol. 2021. PMID: 33708125 Free PMC article.
Effectiveness of Chinese herbal medicine combined with Western medicine on deferring dialysis initiation for nondialysis chronic kidney disease stage 5 patients: a multicenter prospective nonrandomized controlled study.
Wu Y, Li C, Zhang L, Zou C, Xu P, Wen Z, Ouyang W, Yang N, Zhang M, Lin Q, Lu F, Wang L, Bao K, Zhao D, Fu L, Guo X, Yang L, Ou A, He Z, Weng H, Li J, Shi W, Wang X, Song L, Zhan Y, Sun W, Wei L, Wang N, Gui D, Zhan J, Lu Y, Chen H, Liu Y, Yang H, Chen M, Wang Y, Zhang P, Deng Y, Meng L, Cheng X, Li F, Yu D, Xu D, Fang J, Li H, Fu J, Xie Y, Li W, Zhao J, Huang Y, Lu Z, Su G, Zhang L, Qin X, Xu Y, Peng Y, Hou H, Deng L, Liu H, Jie X, Liu L, Tang F, Pei H, Li P, Mao W, Liu X. Wu Y, et al. Ann Transl Med. 2021 Mar;9(6):490. doi: 10.21037/atm-21-871. Ann Transl Med. 2021. PMID: 33850887 Free PMC article.
991 results